May 2011

Genomic Testing and Therapies for Breast Cancer in Clinical Practice

May 15, 2011


Despite almost universal testing for human-epidermal-growth-factor-receptor-2 (HER2), many women with a HER2-positive cancer may not receive trastuzumab. Fewer women received the newer gene-expression-profile (GEP) test.

Journey Forward: The New Face of Cancer Survivorship Care

May 13, 2011


WellPoint, UCLA's Jonsson Comprehensive Cancer Center, the National Coalition for Cancer Survivorship (NCCS) and Genentech collaborated to develop Journey Forward, a first-of-its-kind program for coordinating post-treatment care.